Hypoglycemia Unawareness in IDDM
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Hypoglycemia unawareness—loss of the neurogenic (autonomic) warning symptoms of developing hypoglycemia—is one of three hypoglycemia-associated clinical syndromes that exemplify hypoglycemia-associated autonomic failure in IDDM. Reduced awareness of developing hypoglycemia (an elevated glycemic threshold for symptoms) is a feature not only of hypoglycemia unawareness but also of the syndromes of defective glucose counterregulation, elevated glycemic thresholds for symptoms, and activation of glucose counterregulatory systems during effective intensive therapy. These syndromes are major risk factors for severe iatrogenic hypoglycemia in individuals with IDDM. Their pathogenesis is unknown and likely multifactorial. Recent antecedent iatrogenic hypoglycemia may be one factor, perhaps a major factor, that, by reducing both the symptoms of and defenses against developing hypoglycemia, results in recurrent iatrogenic hypoglycemia, thus creating a vicious cycle. On the other hand, treatment with human compared with animal insulin does not appear to be an important factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Self-citationSchwartz, N. S., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112884 · Cited by 394 · cited 2×
“It is now well documented that there is an order to the responses to hypoglycemia (33,34).”
BackgroundSelf-citationEffect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel, S. A., Sherwin, R. S., Simonson, D. C., & Tamborlane, W. V. (1988) · Diabetes · doi:10.2337/diab.37.7.901 · Cited by 393
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391 · cited 1×
“These are: 1) hypoglycemia unawareness (1,6-14); 2) defective glucose counterregulation attributable to the combined deficiencies of the glucagon and epinephrine secretory responses to falling plasma glucose concentrations (1,12,13,15-19); and 3) elevated glycemic thresholds (lower plasma glucose concentrations requir…”
BackgroundSelf-citationBoyle, P. J., Schwartz, N. S., Shah, S. D., Clutter, W. E., & Cryer, P. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182302 · Cited by 258
Self-citationCounterregulatory adaptation to recurrent hypoglycemia in normal humans
DAVIS, M. R., & SHAMOON, H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-995 · Cited by 143 · cited 2×
“Although there is general agreement that neurogenic symptomatic and autonomic neuroendocrine responses to hypoglycemia are reduced after an episode of antecedent hypoglycemia (38-40), there is less agreement concerning the neuroglycopenic symptomatic and cognitive responses.”
BackgroundBERLIN, I., GRIMALDI, A., LANDAULT, C., ZOGHBI, F., THERVET, F., PUECH, A. J., & LEGRAND, J. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-273 · Cited by 32 · cited 1×
“(35) have reported reduced cardiac chronotropic sensitivity to the (3-adrenergic agonist isoproterenol in IDDM patients with clinical hypoglycemia unawareness.”
BackgroundHypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans
Heller, S. R., & Cryer, P. E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.1.e41 · Cited by 26 · cited 1×
“However, glucose counterregulatory (plasma glucose-raising) systems normally prevent hypoglycemia, particularly severe symptomatic hypoglycemia, during less marked hyperinsulinemia (5).”
BackgroundSelf-citation
Cited by
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Kawamori, D., Kurpad, A. J., Hu, J., Liew, C. W., Shih, J. L., Ford, E. L., Herrera, P. L., Polonsky, K. S., McGuinness, O. P., & Kulkarni, R. N. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.007 · Cited by 316
Symptoms of hypoglycaemia in people with diabetes
McAulay, V., Deary, I. J., & Frier, B. M. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00620.x · Cited by 264
Recall of severe hypoglycaemia and self‐estimated state of awareness in type 1 diabetes
Pedersen‐Bjergaard, U., Pramming, S., & Thorsteinsson, B. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.377 · Cited by 240
A Pilot Study of the Continuous Glucose Monitoring System
Kaufman, F. R., Gibson, L. C., Halvorson, M., Carpenter, S., Fisher, L. K., & Pitukcheewanont, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2030 · Cited by 224
Hypoglycaemia and cognitive function
Warren, R. E., & Frier, B. M. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00421.x · Cited by 218
Smith, C. B., Choudhary, P., Pernet, A., Hopkins, D., & Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-2259 · Cited by 106
Fritsche, A., Stefan, N., Häring, H., Gerich, J., & Stumvoll, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_1-200105010-00009 · Cited by 98
Effects of Glycemic Control on Protective Responses Against Hypoglycemia in Type 2 Diabetes
Korzon-Burakowska, A., Hopkins, D., Matyka, K., Lomas, J., Pernet, A., Macdonald, I., & Amiel, S. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.283 · Cited by 71
Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes
Zammitt, N. N., Warren, R. E., Deary, I. J., & Frier, B. M. (2008) · Diabetes · doi:10.2337/db07-0695 · Cited by 61
“Cognitive dysfunction begins at lower blood glucose levels in people with type 1 diabetes and IHA compared with those with NHA (13), and antecedent hypoglycemia in individuals with type 1 diabetes and NHA can shift the thresholds for cognitive dysfunction to lower blood glucose levels (9,10,22,23).”
BackgroundImpaired hypoglycaemia awareness in type 1 diabetes: Lessons from the lab
McNeilly, A. D., & McCrimmon, R. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4548-8 · Cited by 55
Hypoglycemia in Type 1 Diabetes Mellitus: Pathophysiology and Prevention
Dagogo-Jack, S. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00004 · Cited by 40
Verhulst, C. E. M., Fabricius, T. W., Teerenstra, S., Kristensen, P. L., Tack, C. J., McCrimmon, R. J., Heller, S., Evans, M. L., Amiel, S. A., Pedersen-Bjergaard, U., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05749-8 · Cited by 34
McNay, E. C., Teske, J. A., Kotz, C. M., Dunn-Meynell, A., Levin, B. E., McCrimmon, R. J., & Sherwin, R. S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2012 · Cited by 31
Fritsche, A., Stumvoll, M., Häring, H. U., & Gerich, J. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6353 · Cited by 28
de Galan, B. E., Rietjens, S. J., Tack, C. J., van der Werf, S. P., Sweep, C. G. J. (., W. M. Lenders, J., & Smits, P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030407 · Cited by 12
Hoffman, E. G., Jahangiriesmaili, M., Mandel, E. R., Greenberg, C., Aiken, J., D’Souza, N. C., Pasieka, A., Teich, T., Chan, O., Liggins, R., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab189 · Cited by 11
Metadata
- Authors
- Cryer, P. E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1993-12-01
- Volume
- 16
- Issue
- Supplement_3
- Pages
- 40-47
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1969921716
- Cited by
- 112
- References
- 8
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.